Pair of Failed Studies Prompts Biogen to Drop Arthritis Drug
By Catherine Hollingsworth
Monday, October 13, 2008
Biogen Idec Inc. is stopping development of an investigational arthritis drug due to negative results from two studies that aimed to measure the drug's effectiveness. (BioWorld Today)
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.